Albiges, L., Suarez, C., Powles, T., Motzer, R. J., Stadler, W. M., Miller, W. H., Rojas, C., Peer, A., Goh, J. C., Park, S. H., Waddell, T., Barthélémy, P., Gajate, P., Weickhardt, A., Faust, G., Perini, R. F., Bousserouel, L., Wang, D., Hammers, H. J., Beckermann, K. (2025). KEYMAKER-U03 Substudy 03B: Pembrolizumab (pembro) and targeted therapy combinations for advanced clear cell renal cell carcinoma (ccRCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.440